Serum c-reactive protein level in COPD patients and normal population

Tanaffos

Volumn 6, Issue 2, 2007, Pages 51-55

  Halvani, Abolhassan ^a   Nadooshan, Hossein Hadi ^a   Shoraki, Fatemeh Kargar ^a   Nasiriani, Khadijeh ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Chronic obstructive pulmonary disease; Normal population

Indexed keywords

C REACTIVE PROTEIN; STEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DESCRIPTIVE RESEARCH; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISCHEMIC HEART DISEASE; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RANK SUM TEST;

EID: 77953373426     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17 (5): 982-94.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349 (9064): 1498-504.
3. Cote CG. Surrogates of mortality in chronic obstructive pulmonary disease. Am J Med 2006; 119 (10 Suppl 1): 54-62.
4. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61 (1): 10-6.
5. Wu SJ, Chen P, Jiang XN, Liu ZJ. C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005; 30 (4): 444-6.
6. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107 (3): 363-9.
7. Clearfield MB. C-reactive protein: A new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 2005; 105 (9): 409-16.
8. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107 (11): 1514-9.
9. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 2005; 127 (2): 558-64.
10. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available at: Www.goldcopd.com.Accessed July 6, 2006.
11. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; 152 (5 Pt 2): S77-121.
12. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006; 61 (1): 17-22.
13. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano SB, Vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61 (1): 23-8.
14. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27 (5): 902-7.
15. Schneider A, Dinant GJ, Maag I, Gantner L, Meyer JF, Szecsenyi J. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: Results of a diagnostic study in primary care. BMC Fam Pract 2006; 7: 28.
16. Tina L, Blazogiannakis G, Koutzas S, Theodoropoulou D, Tzannes S. The role of CRP levels measurement in patients with COPD exacerbation. Pneumon 2001, 14(1): 70-73
17. Paul Man and Sin DD. Effect Of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. The proceeding of the American Thoracic Society 2005; 2: 78-82
18. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170 (7): 760-5.